Honeywell International’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-128,000
| Closed | -$12.5M | – | 149 |
|
|
2018
Q4 | $12.5M | Buy |
128,000
+400
| +0.3% | +$38.9K | 0.82% | 46 |
|
|
2018
Q3 | $17.7M | Buy |
127,600
+37,900
| +42% | +$5.27M | 1.01% | 32 |
|
|
2018
Q2 | $11.1M | Sell |
89,700
-33,000
| -27% | -$4.1M | 0.67% | 62 |
|
|
2018
Q1 | $13.7M | Sell |
122,700
-106,800
| -47% | -$11.9M | 0.8% | 54 |
|
|
2017
Q4 | $27.4M | Buy |
229,500
+40,100
| +21% | +$4.8M | 0.91% | 48 |
|
|
2017
Q3 | $26.6M | Buy |
189,400
+100
| +0.1% | +$14K | 0.93% | 45 |
|
|
2017
Q2 | $23M | Hold |
189,300
| – | – | 0.87% | 43 |
|
|
2017
Q1 | $23M | Sell |
189,300
-56,400
| -23% | -$6.84M | 0.74% | 48 |
|
|
2016
Q4 | $30.1M | Buy |
245,700
+69,700
| +40% | +$8.53M | 1.01% | 26 |
|
|
2016
Q3 | $21.6M | Buy |
+176,000
| New | +$21.6M | 0.75% | 44 |
|